# Randomized Controlled Trial of Subconjunctival Bevacizumab Injection in Impending Recurrent Pterygium

> **NCT01288404** · NA · COMPLETED · sponsor: **Ramathibodi Hospital** · enrollment: 80 (actual)

## Conditions studied

- Pterygium of the Conjunctiva and Cornea

## Interventions

- **DRUG:** Fluorometholone
- **DRUG:** Bevacizumab
- **DRUG:** Bevacizumab
- **DRUG:** Bevacizumab

## Key facts

- **NCT ID:** NCT01288404
- **Lead sponsor:** Ramathibodi Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-01
- **Primary completion:** 2010-09
- **Final completion:** 2010-11
- **Target enrollment:** 80 (ACTUAL)
- **Last updated:** 2011-02-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01288404

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01288404, "Randomized Controlled Trial of Subconjunctival Bevacizumab Injection in Impending Recurrent Pterygium". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT01288404. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*